WebDec 16, 2024 · Poortmans: After the publication of the results of the FAST-Forward trial, with a median follow-up of 71.5 months, ultra-hypofractionated RT clearly became the new standard for breast only and for thoracic wall only . Moreover, it is an option for chest wall after breast reconstruction. WebMay 13, 2024 · Results from the UK’s FAST-Forward trial – published in April 2024 as the COVID-19 pandemic started to escalate – revealed that using higher doses of radiotherapy over five days for post-operative breast cancer patients was as safe and effective as using lower doses over a three week course.
(PDF) Moderate hypofractionation remains the standard of
WebJan 20, 2024 · The non-inferiority and safety of 26Gy/5 fractions in comparison to the standard 40Gy/15 fractions of adjuvant RT in early-stage breast cancer has been established in light of the fast-forward trial results. The aim of our study was to assess the feasibility and comparable toxicity of the ultrahypofractionated regime as a real-world … WebFast-Forward trial randomisation diagram After radiotherapy everyone had a check up with their doctor once a year. Results The team followed everyone up for about 5 years. … smsf home loans comparison
Expert Discussion: Hypofractionated Radiation Therapy – Standard …
WebApr 28, 2024 · report the 5-year results of a three-arm, multicentre, randomised controlled, phase 3, non-inferiority trial (FAST-Forward) in which 4096 patients with invasive carcinoma of the breast were randomly … WebApr 28, 2024 · The objectives are to identify a 1-week schedule non-inferior to a standard 3-week regimen for 5-year local tumour control and similar in terms of late adverse effects. FAST-Forward was informed by the FAST trial that tested two dose levels of five once-weekly fractions;13, 14 FAST trial results to 10-year follow-up are to be published soon ... WebAs far as the radiation technique is concerned, the FAST-Forward trial applied a 3-dimensional computed tomography ... (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013;14:1086-94. rk group.com